Susan Garfield is a market access, reimbursement, and economics strategist, with expertise in demand creation and advocacy. For more than 12 years, her professional career has focused on women's health, innovations in health care, the economics of practice change, and the role of reimbursement and policy to the adoption of new technologies.Ms. Garfield is currently vice president at Bridgehead International, where she runs the Boston office of the market access consulting practice. At Bridgehead, Ms. Garfield works to help companies navigate the complexities of bringing innovative health-care technologies to market. Prior to joining Bridgehead, Ms. Garfield was the Director of Global Reimbursement Policy and Economic Strategy at QIAGEN, Inc. (formerly Digene Corporation). In this role, she planned and executed a reimbursement strategy that resulted in near universal coverage for the company's leading cancer diagnostic product. In addition, she directed global economic and pricing analyses for the company's clinical diagnostic portfolio. Before QIAGEN, Ms. Garfield was a director at Boston Healthcare Consulting. During her tenure there, Ms. Garfield worked with biotechnology, medical device, pharmaceutical, and diagnostic firms on market access strategy and execution. In this role she translated primary research with more than 2,000 clinicians, payers, government decision makers, and patients into actionable programs for clients.Ms. Garfield received her baccalaureate degree in English and women's studies from the University of Pennsylvania, a master's of science in population and development from the London School of Economics, and a master's degree in health policy and management from Harvard University, School of Public Health. Ms. Garfield is currently pursuing her doctorate of public health at Boston University.
